Suppose we woke to the following headline with our morning coffee: Obama Administration to Fund 13 New Experimental HIV Drugs, followed by this secondary header: Activist Groups Outraged at Funding ‘Useless’ Class of Drugs over Proven Entity.
Indeed, suppose the story went on to describe how the President and the Democrats remained wedded to funding a class of drugs whose side-effects were so horrendous in animal research models that use in humans would be unthinkable.
Further suppose that the classes of drugs that have shown dramatic efficacy went underfunded, and were even ridiculed by the President and his fellow travelers. Imagine that states such as California floated $3 Billion bonds to float such useless research into drugs that couldn’t make it out of animal trials over drugs working in human HIV/AIDS patients. Imagine the outrage coming from the scientific and medical communities, from AIDS activists, AIDS patients and their loved ones.
There would be calls for Congressional hearings. There would be protests that would make the HIV protests of the 1980′s look tame by comparison.
Certainly people would wonder why. Why would the federal and state governments obstinately sink tens of billions of dollars into such fruitless research and allow other nations to capitalize on the existing research bearing good fruit?
Absent a mass delusion as an explanation, people would be looking for a smoking gun.
Thus it is with Embryonic Stem Cells (ESC’s) vs. Adult Stem Cells (ASC’s). Thus it has been this week with President Obama. Read more.